COX-3: Fact or fancy?

Joint Bone Spine

Volumn 71, Issue 6, 2004, Pages 451-453

  Berenbaum, Francis ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Acetaminophen; Cyclooxygenase; NSAID; Paracetamol

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE;

ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; BRAIN CORTEX; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVITY; HUMAN; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; HUMANS; INFLAMMATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 10344262035     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.02.003     Document Type: Editorial

References (19)

1. Berenbaum F. Cyclooxygenases and cyclooxygenase inhibitors: is a new class of drugs in the making? Rev Rhum Engl Ed. 65:1998;634-640
2. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 343:2000;1520-1528
3. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A., et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA. 284:2000;1247-1255
4. Crofford L.J. Is there a place for non-selective NSAIDs in the treatment of arthritis? Joint Bone Spine. 69:2002;4-7
5. Willoughby D.A., Moore A.R., Colville-Nash P.R. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 355:2000;646-648
6. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 5:1999;698-701
7. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 196:2002;1025-1037
8. Schwab J.M., Schluesener H.J., Meyermann R., Serhan C.N. COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics? Prostaglandins Leukot Essent Fatty Acids. 69:2003;339-343
9. Botting R.M. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 31:(Suppl 5):2000;S202-S210
10. Flower R.J., Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 240:1972;410-411
11. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 410:2001;471-475
12. Simmons D.L., Botting R.M., Robertson P.M., Madsen M.L., Vane J.R. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci USA. 96:1999;3275-3280
13. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 99:2002;13926-13931
14. Shaftel S.S., Olschowka J.A., Hurley S.D., Moore A.H., O'Banion M.K. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res. 119:2003;213-215
15. Schwab J.M., Schluesener H.J., Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet. 361:2003;981-982
16. Schwab J.M., Beiter T., Linder J.U., Laufer S., Schulz J.E., Meyermann R., et al. COX-3 - a virtual pain target in humans? FASEB J. 1715:2003;2174-2175
17. Dinchuk J.E., Liu R.Q., Trzaskos J.M. COX-3: in the wrong frame in mind. Immunol Lett. 86:(1):2003;121
18. Warner T.D., Mitchell J.A. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA. 99:2002;13371-13373
19. Simmons D. Variants of cyclooxygenase-1 and their roles in medicine. Thromb Res. 110:2003;265-268